nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ACHE—Irinotecan—stomach cancer	0.291	0.381	CbGbCtD
Neostigmine—BCHE—Irinotecan—stomach cancer	0.175	0.229	CbGbCtD
Neostigmine—ABCB1—Mitomycin—stomach cancer	0.173	0.227	CbGbCtD
Neostigmine—ABCB1—Irinotecan—stomach cancer	0.0445	0.0582	CbGbCtD
Neostigmine—ABCB1—Docetaxel—stomach cancer	0.0326	0.0426	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—stomach cancer	0.0243	0.0318	CbGbCtD
Neostigmine—ABCB1—Methotrexate—stomach cancer	0.0235	0.0308	CbGbCtD
Neostigmine—BCHE—diaphragm—stomach cancer	0.0108	0.505	CbGeAlD
Neostigmine—BCHE—hematopoietic system—stomach cancer	0.00113	0.0527	CbGeAlD
Neostigmine—ABCB1—blood vessel—stomach cancer	0.00101	0.0472	CbGeAlD
Neostigmine—BCHE—smooth muscle tissue—stomach cancer	0.000992	0.0464	CbGeAlD
Neostigmine—ACHE—lymph node—stomach cancer	0.000911	0.0426	CbGeAlD
Neostigmine—BCHE—digestive system—stomach cancer	0.000784	0.0366	CbGeAlD
Neostigmine—BCHE—bone marrow—stomach cancer	0.000722	0.0338	CbGeAlD
Neostigmine—BCHE—endocrine gland—stomach cancer	0.000647	0.0303	CbGeAlD
Neostigmine—BCHE—liver—stomach cancer	0.000584	0.0273	CbGeAlD
Neostigmine—Flatulence—Irinotecan—stomach cancer	0.000555	0.00297	CcSEcCtD
Neostigmine—Arrhythmia—Fluorouracil—stomach cancer	0.000554	0.00296	CcSEcCtD
Neostigmine—Bronchospasm—Docetaxel—stomach cancer	0.00055	0.00294	CcSEcCtD
Neostigmine—Coma—Epirubicin—stomach cancer	0.000549	0.00294	CcSEcCtD
Neostigmine—Muscle spasms—Irinotecan—stomach cancer	0.000542	0.0029	CcSEcCtD
Neostigmine—Salivary hypersecretion—Doxorubicin—stomach cancer	0.00054	0.00289	CcSEcCtD
Neostigmine—ABCB1—hematopoietic system—stomach cancer	0.000537	0.0251	CbGeAlD
Neostigmine—Bronchospasm—Capecitabine—stomach cancer	0.000532	0.00285	CcSEcCtD
Neostigmine—Sweating increased—Capecitabine—stomach cancer	0.000527	0.00282	CcSEcCtD
Neostigmine—Coma—Doxorubicin—stomach cancer	0.000508	0.00272	CcSEcCtD
Neostigmine—Syncope—Irinotecan—stomach cancer	0.000505	0.0027	CcSEcCtD
Neostigmine—Loss of consciousness—Irinotecan—stomach cancer	0.000495	0.00265	CcSEcCtD
Neostigmine—ABCB1—epithelium—stomach cancer	0.000491	0.023	CbGeAlD
Neostigmine—Convulsion—Fluorouracil—stomach cancer	0.000468	0.0025	CcSEcCtD
Neostigmine—Osteoarthritis—Methotrexate—stomach cancer	0.000466	0.00249	CcSEcCtD
Neostigmine—Anaphylactic shock—Irinotecan—stomach cancer	0.00046	0.00246	CcSEcCtD
Neostigmine—Shock—Irinotecan—stomach cancer	0.000452	0.00242	CcSEcCtD
Neostigmine—Nervous system disorder—Irinotecan—stomach cancer	0.000451	0.00241	CcSEcCtD
Neostigmine—BCHE—lymph node—stomach cancer	0.000448	0.0209	CbGeAlD
Neostigmine—Hyperhidrosis—Irinotecan—stomach cancer	0.000445	0.00238	CcSEcCtD
Neostigmine—Urinary tract disorder—Docetaxel—stomach cancer	0.000442	0.00236	CcSEcCtD
Neostigmine—Bradycardia—Capecitabine—stomach cancer	0.000441	0.00236	CcSEcCtD
Neostigmine—Anaphylactic shock—Fluorouracil—stomach cancer	0.00044	0.00236	CcSEcCtD
Neostigmine—Connective tissue disorder—Docetaxel—stomach cancer	0.00044	0.00235	CcSEcCtD
Neostigmine—Urethral disorder—Docetaxel—stomach cancer	0.000439	0.00235	CcSEcCtD
Neostigmine—ABCB1—pancreas—stomach cancer	0.000437	0.0205	CbGeAlD
Neostigmine—Osteoarthritis—Epirubicin—stomach cancer	0.000436	0.00233	CcSEcCtD
Neostigmine—Nervous system disorder—Fluorouracil—stomach cancer	0.000432	0.00231	CcSEcCtD
Neostigmine—Tachycardia—Fluorouracil—stomach cancer	0.00043	0.0023	CcSEcCtD
Neostigmine—Hypotension—Irinotecan—stomach cancer	0.00043	0.0023	CcSEcCtD
Neostigmine—Urinary tract disorder—Capecitabine—stomach cancer	0.000428	0.00229	CcSEcCtD
Neostigmine—Connective tissue disorder—Capecitabine—stomach cancer	0.000426	0.00228	CcSEcCtD
Neostigmine—Urethral disorder—Capecitabine—stomach cancer	0.000425	0.00227	CcSEcCtD
Neostigmine—Insomnia—Irinotecan—stomach cancer	0.000416	0.00222	CcSEcCtD
Neostigmine—Flushing—Docetaxel—stomach cancer	0.000415	0.00222	CcSEcCtD
Neostigmine—Cardiac arrest—Epirubicin—stomach cancer	0.000415	0.00222	CcSEcCtD
Neostigmine—Hypotension—Fluorouracil—stomach cancer	0.000412	0.0022	CcSEcCtD
Neostigmine—Dyspnoea—Irinotecan—stomach cancer	0.00041	0.00219	CcSEcCtD
Neostigmine—Somnolence—Irinotecan—stomach cancer	0.000409	0.00219	CcSEcCtD
Neostigmine—Osteoarthritis—Doxorubicin—stomach cancer	0.000404	0.00216	CcSEcCtD
Neostigmine—Mediastinal disorder—Docetaxel—stomach cancer	0.000403	0.00216	CcSEcCtD
Neostigmine—Flushing—Capecitabine—stomach cancer	0.000402	0.00215	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000401	0.00215	CcSEcCtD
Neostigmine—Arrhythmia—Docetaxel—stomach cancer	0.0004	0.00214	CcSEcCtD
Neostigmine—Insomnia—Fluorouracil—stomach cancer	0.000398	0.00213	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000397	0.00212	CcSEcCtD
Neostigmine—Dyspnoea—Fluorouracil—stomach cancer	0.000393	0.0021	CcSEcCtD
Neostigmine—Mental disorder—Docetaxel—stomach cancer	0.000392	0.0021	CcSEcCtD
Neostigmine—Somnolence—Fluorouracil—stomach cancer	0.000392	0.00209	CcSEcCtD
Neostigmine—Mediastinal disorder—Capecitabine—stomach cancer	0.00039	0.00209	CcSEcCtD
Neostigmine—Arrhythmia—Capecitabine—stomach cancer	0.000387	0.00207	CcSEcCtD
Neostigmine—Cardiac arrest—Doxorubicin—stomach cancer	0.000384	0.00205	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00038	0.00203	CcSEcCtD
Neostigmine—Mental disorder—Capecitabine—stomach cancer	0.00038	0.00203	CcSEcCtD
Neostigmine—ABCB1—lymphoid tissue—stomach cancer	0.000378	0.0177	CbGeAlD
Neostigmine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000376	0.00201	CcSEcCtD
Neostigmine—Muscle spasms—Docetaxel—stomach cancer	0.000374	0.002	CcSEcCtD
Neostigmine—ABCB1—digestive system—stomach cancer	0.000373	0.0175	CbGeAlD
Neostigmine—Flatulence—Capecitabine—stomach cancer	0.000372	0.00199	CcSEcCtD
Neostigmine—Abdominal pain—Irinotecan—stomach cancer	0.000364	0.00194	CcSEcCtD
Neostigmine—Muscle spasms—Capecitabine—stomach cancer	0.000363	0.00194	CcSEcCtD
Neostigmine—Drowsiness—Methotrexate—stomach cancer	0.000359	0.00192	CcSEcCtD
Neostigmine—Urticaria—Fluorouracil—stomach cancer	0.00035	0.00187	CcSEcCtD
Neostigmine—Syncope—Docetaxel—stomach cancer	0.000349	0.00187	CcSEcCtD
Neostigmine—Pollakiuria—Epirubicin—stomach cancer	0.000348	0.00186	CcSEcCtD
Neostigmine—ABCB1—bone marrow—stomach cancer	0.000344	0.0161	CbGeAlD
Neostigmine—Loss of consciousness—Docetaxel—stomach cancer	0.000342	0.00183	CcSEcCtD
Neostigmine—Hypersensitivity—Irinotecan—stomach cancer	0.000339	0.00181	CcSEcCtD
Neostigmine—Syncope—Capecitabine—stomach cancer	0.000338	0.00181	CcSEcCtD
Neostigmine—Convulsion—Docetaxel—stomach cancer	0.000337	0.00181	CcSEcCtD
Neostigmine—Drowsiness—Epirubicin—stomach cancer	0.000336	0.0018	CcSEcCtD
Neostigmine—Arthralgia—Docetaxel—stomach cancer	0.000332	0.00177	CcSEcCtD
Neostigmine—Loss of consciousness—Capecitabine—stomach cancer	0.000331	0.00177	CcSEcCtD
Neostigmine—Asthenia—Irinotecan—stomach cancer	0.00033	0.00176	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000329	0.00176	CcSEcCtD
Neostigmine—Hypersensitivity—Fluorouracil—stomach cancer	0.000324	0.00174	CcSEcCtD
Neostigmine—Dry mouth—Docetaxel—stomach cancer	0.000324	0.00173	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—stomach cancer	0.000322	0.00172	CcSEcCtD
Neostigmine—Arthralgia—Capecitabine—stomach cancer	0.000321	0.00172	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000319	0.00171	CcSEcCtD
Neostigmine—Urinary tract disorder—Methotrexate—stomach cancer	0.000318	0.0017	CcSEcCtD
Neostigmine—Anaphylactic shock—Docetaxel—stomach cancer	0.000318	0.0017	CcSEcCtD
Neostigmine—Urethral disorder—Methotrexate—stomach cancer	0.000316	0.00169	CcSEcCtD
Neostigmine—Diarrhoea—Irinotecan—stomach cancer	0.000315	0.00168	CcSEcCtD
Neostigmine—Dry mouth—Capecitabine—stomach cancer	0.000314	0.00168	CcSEcCtD
Neostigmine—Shock—Docetaxel—stomach cancer	0.000313	0.00167	CcSEcCtD
Neostigmine—Nervous system disorder—Docetaxel—stomach cancer	0.000312	0.00167	CcSEcCtD
Neostigmine—Pruritus—Fluorouracil—stomach cancer	0.000312	0.00167	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—stomach cancer	0.000311	0.00166	CcSEcCtD
Neostigmine—Tachycardia—Docetaxel—stomach cancer	0.00031	0.00166	CcSEcCtD
Neostigmine—Skin disorder—Docetaxel—stomach cancer	0.000309	0.00165	CcSEcCtD
Neostigmine—ABCB1—endocrine gland—stomach cancer	0.000309	0.0144	CbGeAlD
Neostigmine—Bradycardia—Epirubicin—stomach cancer	0.000307	0.00164	CcSEcCtD
Neostigmine—Dizziness—Irinotecan—stomach cancer	0.000304	0.00163	CcSEcCtD
Neostigmine—Shock—Capecitabine—stomach cancer	0.000303	0.00162	CcSEcCtD
Neostigmine—Nervous system disorder—Capecitabine—stomach cancer	0.000302	0.00161	CcSEcCtD
Neostigmine—Diarrhoea—Fluorouracil—stomach cancer	0.000301	0.00161	CcSEcCtD
Neostigmine—Tachycardia—Capecitabine—stomach cancer	0.0003	0.00161	CcSEcCtD
Neostigmine—Skin disorder—Capecitabine—stomach cancer	0.000299	0.0016	CcSEcCtD
Neostigmine—Urinary tract disorder—Epirubicin—stomach cancer	0.000298	0.00159	CcSEcCtD
Neostigmine—Hyperhidrosis—Capecitabine—stomach cancer	0.000298	0.00159	CcSEcCtD
Neostigmine—Hypotension—Docetaxel—stomach cancer	0.000297	0.00159	CcSEcCtD
Neostigmine—Connective tissue disorder—Epirubicin—stomach cancer	0.000297	0.00159	CcSEcCtD
Neostigmine—Urethral disorder—Epirubicin—stomach cancer	0.000296	0.00158	CcSEcCtD
Neostigmine—Vomiting—Irinotecan—stomach cancer	0.000292	0.00156	CcSEcCtD
Neostigmine—Dizziness—Fluorouracil—stomach cancer	0.000291	0.00156	CcSEcCtD
Neostigmine—Mediastinal disorder—Methotrexate—stomach cancer	0.000291	0.00155	CcSEcCtD
Neostigmine—Rash—Irinotecan—stomach cancer	0.00029	0.00155	CcSEcCtD
Neostigmine—Dermatitis—Irinotecan—stomach cancer	0.00029	0.00155	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00029	0.00155	CcSEcCtD
Neostigmine—Headache—Irinotecan—stomach cancer	0.000288	0.00154	CcSEcCtD
Neostigmine—Hypotension—Capecitabine—stomach cancer	0.000288	0.00154	CcSEcCtD
Neostigmine—Insomnia—Docetaxel—stomach cancer	0.000288	0.00154	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—stomach cancer	0.000284	0.00152	CcSEcCtD
Neostigmine—Dyspnoea—Docetaxel—stomach cancer	0.000283	0.00152	CcSEcCtD
Neostigmine—Somnolence—Docetaxel—stomach cancer	0.000283	0.00151	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—stomach cancer	0.000283	0.00151	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00028	0.0015	CcSEcCtD
Neostigmine—Flushing—Epirubicin—stomach cancer	0.00028	0.0015	CcSEcCtD
Neostigmine—Vomiting—Fluorouracil—stomach cancer	0.00028	0.0015	CcSEcCtD
Neostigmine—Insomnia—Capecitabine—stomach cancer	0.000278	0.00149	CcSEcCtD
Neostigmine—ABCB1—liver—stomach cancer	0.000278	0.013	CbGeAlD
Neostigmine—Rash—Fluorouracil—stomach cancer	0.000278	0.00149	CcSEcCtD
Neostigmine—Dermatitis—Fluorouracil—stomach cancer	0.000277	0.00148	CcSEcCtD
Neostigmine—Headache—Fluorouracil—stomach cancer	0.000276	0.00148	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000276	0.00148	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000274	0.00147	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—stomach cancer	0.000274	0.00147	CcSEcCtD
Neostigmine—Dyspnoea—Capecitabine—stomach cancer	0.000274	0.00147	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—stomach cancer	0.000274	0.00146	CcSEcCtD
Neostigmine—Nausea—Irinotecan—stomach cancer	0.000273	0.00146	CcSEcCtD
Neostigmine—Mediastinal disorder—Epirubicin—stomach cancer	0.000272	0.00145	CcSEcCtD
Neostigmine—Arrhythmia—Epirubicin—stomach cancer	0.00027	0.00144	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000266	0.00142	CcSEcCtD
Neostigmine—Mental disorder—Epirubicin—stomach cancer	0.000264	0.00141	CcSEcCtD
Neostigmine—Nausea—Fluorouracil—stomach cancer	0.000262	0.0014	CcSEcCtD
Neostigmine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00026	0.00139	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—stomach cancer	0.000259	0.00139	CcSEcCtD
Neostigmine—Flatulence—Epirubicin—stomach cancer	0.000259	0.00138	CcSEcCtD
Neostigmine—Muscle spasms—Epirubicin—stomach cancer	0.000253	0.00135	CcSEcCtD
Neostigmine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000252	0.00135	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000252	0.00135	CcSEcCtD
Neostigmine—Abdominal pain—Docetaxel—stomach cancer	0.000251	0.00134	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—stomach cancer	0.000249	0.00133	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—stomach cancer	0.000245	0.00131	CcSEcCtD
Neostigmine—Urticaria—Capecitabine—stomach cancer	0.000244	0.00131	CcSEcCtD
Neostigmine—Abdominal pain—Capecitabine—stomach cancer	0.000243	0.0013	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—stomach cancer	0.000243	0.0013	CcSEcCtD
Neostigmine—Agitation—Epirubicin—stomach cancer	0.000241	0.00129	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—stomach cancer	0.00024	0.00128	CcSEcCtD
Neostigmine—Arthralgia—Methotrexate—stomach cancer	0.000239	0.00128	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000237	0.00127	CcSEcCtD
Neostigmine—Syncope—Epirubicin—stomach cancer	0.000236	0.00126	CcSEcCtD
Neostigmine—Hypersensitivity—Docetaxel—stomach cancer	0.000234	0.00125	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—stomach cancer	0.000234	0.00125	CcSEcCtD
Neostigmine—Loss of consciousness—Epirubicin—stomach cancer	0.000231	0.00124	CcSEcCtD
Neostigmine—Anaphylactic shock—Methotrexate—stomach cancer	0.000229	0.00123	CcSEcCtD
Neostigmine—Asthenia—Docetaxel—stomach cancer	0.000228	0.00122	CcSEcCtD
Neostigmine—Convulsion—Epirubicin—stomach cancer	0.000228	0.00122	CcSEcCtD
Neostigmine—Hypersensitivity—Capecitabine—stomach cancer	0.000227	0.00121	CcSEcCtD
Neostigmine—Pruritus—Docetaxel—stomach cancer	0.000225	0.0012	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—stomach cancer	0.000225	0.0012	CcSEcCtD
Neostigmine—Arthralgia—Epirubicin—stomach cancer	0.000224	0.0012	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—stomach cancer	0.000223	0.00119	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—stomach cancer	0.000223	0.00119	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000222	0.00119	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—stomach cancer	0.000221	0.00118	CcSEcCtD
Neostigmine—Asthenia—Capecitabine—stomach cancer	0.000221	0.00118	CcSEcCtD
Neostigmine—Dry mouth—Epirubicin—stomach cancer	0.000219	0.00117	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—stomach cancer	0.000218	0.00117	CcSEcCtD
Neostigmine—Pruritus—Capecitabine—stomach cancer	0.000218	0.00116	CcSEcCtD
Neostigmine—Diarrhoea—Docetaxel—stomach cancer	0.000217	0.00116	CcSEcCtD
Neostigmine—Anaphylactic shock—Epirubicin—stomach cancer	0.000214	0.00115	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—stomach cancer	0.000214	0.00115	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—stomach cancer	0.000214	0.00114	CcSEcCtD
Neostigmine—ABCB1—lymph node—stomach cancer	0.000213	0.00998	CbGeAlD
Neostigmine—Shock—Epirubicin—stomach cancer	0.000211	0.00113	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—stomach cancer	0.000211	0.00113	CcSEcCtD
Neostigmine—Diarrhoea—Capecitabine—stomach cancer	0.000211	0.00113	CcSEcCtD
Neostigmine—Nervous system disorder—Epirubicin—stomach cancer	0.00021	0.00112	CcSEcCtD
Neostigmine—Dizziness—Docetaxel—stomach cancer	0.00021	0.00112	CcSEcCtD
Neostigmine—Tachycardia—Epirubicin—stomach cancer	0.000209	0.00112	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000209	0.00112	CcSEcCtD
Neostigmine—Skin disorder—Epirubicin—stomach cancer	0.000208	0.00111	CcSEcCtD
Neostigmine—Hyperhidrosis—Epirubicin—stomach cancer	0.000207	0.00111	CcSEcCtD
Neostigmine—Insomnia—Methotrexate—stomach cancer	0.000207	0.00111	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—stomach cancer	0.000207	0.00111	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000206	0.0011	CcSEcCtD
Neostigmine—Dyspnoea—Methotrexate—stomach cancer	0.000204	0.00109	CcSEcCtD
Neostigmine—Somnolence—Methotrexate—stomach cancer	0.000204	0.00109	CcSEcCtD
Neostigmine—Dizziness—Capecitabine—stomach cancer	0.000204	0.00109	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—stomach cancer	0.000202	0.00108	CcSEcCtD
Neostigmine—Vomiting—Docetaxel—stomach cancer	0.000202	0.00108	CcSEcCtD
Neostigmine—Rash—Docetaxel—stomach cancer	0.0002	0.00107	CcSEcCtD
Neostigmine—Hypotension—Epirubicin—stomach cancer	0.0002	0.00107	CcSEcCtD
Neostigmine—Dermatitis—Docetaxel—stomach cancer	0.0002	0.00107	CcSEcCtD
Neostigmine—Headache—Docetaxel—stomach cancer	0.000199	0.00107	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000198	0.00106	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000198	0.00106	CcSEcCtD
Neostigmine—Vomiting—Capecitabine—stomach cancer	0.000196	0.00105	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000195	0.00104	CcSEcCtD
Neostigmine—Shock—Doxorubicin—stomach cancer	0.000195	0.00104	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—stomach cancer	0.000195	0.00104	CcSEcCtD
Neostigmine—Rash—Capecitabine—stomach cancer	0.000194	0.00104	CcSEcCtD
Neostigmine—Insomnia—Epirubicin—stomach cancer	0.000194	0.00104	CcSEcCtD
Neostigmine—Dermatitis—Capecitabine—stomach cancer	0.000194	0.00104	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—stomach cancer	0.000194	0.00104	CcSEcCtD
Neostigmine—Headache—Capecitabine—stomach cancer	0.000193	0.00103	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—stomach cancer	0.000193	0.00103	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000192	0.00103	CcSEcCtD
Neostigmine—Dyspnoea—Epirubicin—stomach cancer	0.000191	0.00102	CcSEcCtD
Neostigmine—Somnolence—Epirubicin—stomach cancer	0.000191	0.00102	CcSEcCtD
Neostigmine—Nausea—Docetaxel—stomach cancer	0.000189	0.00101	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000187	0.001	CcSEcCtD
Neostigmine—Hypotension—Doxorubicin—stomach cancer	0.000185	0.000992	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000185	0.00099	CcSEcCtD
Neostigmine—Nausea—Capecitabine—stomach cancer	0.000183	0.000978	CcSEcCtD
Neostigmine—Urticaria—Methotrexate—stomach cancer	0.000182	0.000974	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—stomach cancer	0.000181	0.000969	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000181	0.000967	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—stomach cancer	0.000179	0.00096	CcSEcCtD
Neostigmine—Dyspnoea—Doxorubicin—stomach cancer	0.000177	0.000946	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—stomach cancer	0.000176	0.000943	CcSEcCtD
Neostigmine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000175	0.000938	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000171	0.000916	CcSEcCtD
Neostigmine—Urticaria—Epirubicin—stomach cancer	0.00017	0.000911	CcSEcCtD
Neostigmine—Abdominal pain—Epirubicin—stomach cancer	0.000169	0.000907	CcSEcCtD
Neostigmine—Hypersensitivity—Methotrexate—stomach cancer	0.000169	0.000903	CcSEcCtD
Neostigmine—Asthenia—Methotrexate—stomach cancer	0.000164	0.000879	CcSEcCtD
Neostigmine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000162	0.000868	CcSEcCtD
Neostigmine—Pruritus—Methotrexate—stomach cancer	0.000162	0.000867	CcSEcCtD
Neostigmine—Hypersensitivity—Epirubicin—stomach cancer	0.000158	0.000845	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—stomach cancer	0.000158	0.000843	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—stomach cancer	0.000157	0.000839	CcSEcCtD
Neostigmine—Diarrhoea—Methotrexate—stomach cancer	0.000157	0.000838	CcSEcCtD
Neostigmine—Asthenia—Epirubicin—stomach cancer	0.000154	0.000823	CcSEcCtD
Neostigmine—Pruritus—Epirubicin—stomach cancer	0.000152	0.000811	CcSEcCtD
Neostigmine—Dizziness—Methotrexate—stomach cancer	0.000152	0.00081	CcSEcCtD
Neostigmine—Diarrhoea—Epirubicin—stomach cancer	0.000147	0.000785	CcSEcCtD
Neostigmine—Hypersensitivity—Doxorubicin—stomach cancer	0.000146	0.000782	CcSEcCtD
Neostigmine—Vomiting—Methotrexate—stomach cancer	0.000146	0.000779	CcSEcCtD
Neostigmine—Rash—Methotrexate—stomach cancer	0.000144	0.000773	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—stomach cancer	0.000144	0.000772	CcSEcCtD
Neostigmine—Headache—Methotrexate—stomach cancer	0.000144	0.000768	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—stomach cancer	0.000142	0.000761	CcSEcCtD
Neostigmine—Dizziness—Epirubicin—stomach cancer	0.000142	0.000758	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—stomach cancer	0.00014	0.000751	CcSEcCtD
Neostigmine—Vomiting—Epirubicin—stomach cancer	0.000136	0.000729	CcSEcCtD
Neostigmine—Nausea—Methotrexate—stomach cancer	0.000136	0.000728	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—stomach cancer	0.000136	0.000726	CcSEcCtD
Neostigmine—Rash—Epirubicin—stomach cancer	0.000135	0.000723	CcSEcCtD
Neostigmine—Dermatitis—Epirubicin—stomach cancer	0.000135	0.000722	CcSEcCtD
Neostigmine—Headache—Epirubicin—stomach cancer	0.000134	0.000718	CcSEcCtD
Neostigmine—Dizziness—Doxorubicin—stomach cancer	0.000131	0.000702	CcSEcCtD
Neostigmine—Nausea—Epirubicin—stomach cancer	0.000127	0.000681	CcSEcCtD
Neostigmine—Vomiting—Doxorubicin—stomach cancer	0.000126	0.000675	CcSEcCtD
Neostigmine—Rash—Doxorubicin—stomach cancer	0.000125	0.000669	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—stomach cancer	0.000125	0.000668	CcSEcCtD
Neostigmine—Headache—Doxorubicin—stomach cancer	0.000124	0.000665	CcSEcCtD
Neostigmine—Nausea—Doxorubicin—stomach cancer	0.000118	0.00063	CcSEcCtD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—RORA—stomach cancer	7.01e-05	0.00256	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NDUFS1—stomach cancer	7e-05	0.00256	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NDUFV1—stomach cancer	7e-05	0.00256	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—RPS21—stomach cancer	6.85e-05	0.0025	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—RPS15—stomach cancer	6.85e-05	0.0025	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	6.85e-05	0.0025	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—PRKCB—stomach cancer	6.79e-05	0.00248	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	6.74e-05	0.00247	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—IDH3B—stomach cancer	6.72e-05	0.00246	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SUCLG1—stomach cancer	6.72e-05	0.00246	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MUC2—stomach cancer	6.37e-05	0.00233	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	6.36e-05	0.00233	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	6.28e-05	0.0023	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	6.27e-05	0.00229	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NDUFV1—stomach cancer	6.25e-05	0.00228	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NDUFS1—stomach cancer	6.25e-05	0.00228	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—BLVRB—stomach cancer	6.24e-05	0.00228	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PGLS—stomach cancer	6.24e-05	0.00228	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—RPL15—stomach cancer	6.24e-05	0.00228	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—HSPD1—stomach cancer	6.24e-05	0.00228	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	6.11e-05	0.00223	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—PRKCB—stomach cancer	6.06e-05	0.00222	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	5.97e-05	0.00218	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPAP2A—stomach cancer	5.96e-05	0.00218	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—RPS26—stomach cancer	5.82e-05	0.00213	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	5.73e-05	0.00209	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	5.7e-05	0.00209	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PGLS—stomach cancer	5.57e-05	0.00204	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—BLVRB—stomach cancer	5.57e-05	0.00204	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—RPL15—stomach cancer	5.57e-05	0.00204	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—HSPD1—stomach cancer	5.57e-05	0.00204	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CASP8—stomach cancer	5.54e-05	0.00203	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	5.43e-05	0.00199	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPAP2A—stomach cancer	5.31e-05	0.00194	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NDUFA2—stomach cancer	5.31e-05	0.00194	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—FBP1—stomach cancer	5.31e-05	0.00194	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CA1—stomach cancer	5.31e-05	0.00194	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CKB—stomach cancer	5.31e-05	0.00194	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—IGFBP3—stomach cancer	5.27e-05	0.00193	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	5.24e-05	0.00191	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—PRKCB—stomach cancer	5.2e-05	0.0019	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—RPS26—stomach cancer	5.19e-05	0.0019	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	5.12e-05	0.00187	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	5.11e-05	0.00187	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PLIN2—stomach cancer	4.99e-05	0.00182	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	4.96e-05	0.00181	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—RPS19—stomach cancer	4.95e-05	0.00181	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—PAX6—stomach cancer	4.9e-05	0.00179	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CA2—stomach cancer	4.85e-05	0.00177	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	4.85e-05	0.00177	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	4.8e-05	0.00175	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CA1—stomach cancer	4.74e-05	0.00173	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CKB—stomach cancer	4.74e-05	0.00173	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—FBP1—stomach cancer	4.74e-05	0.00173	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NDUFA2—stomach cancer	4.74e-05	0.00173	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NT5E—stomach cancer	4.73e-05	0.00173	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PGAM1—stomach cancer	4.73e-05	0.00173	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGFBP3—stomach cancer	4.7e-05	0.00172	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	4.7e-05	0.00172	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—PRKCB—stomach cancer	4.64e-05	0.0017	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	4.63e-05	0.00169	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	4.62e-05	0.00169	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALDH7A1—stomach cancer	4.51e-05	0.00165	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PLCE1—stomach cancer	4.51e-05	0.00165	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	4.48e-05	0.00164	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PLIN2—stomach cancer	4.45e-05	0.00163	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—RPS19—stomach cancer	4.41e-05	0.00161	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CXCL8—stomach cancer	4.38e-05	0.0016	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—RPS6—stomach cancer	4.38e-05	0.0016	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	4.37e-05	0.0016	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—PAX6—stomach cancer	4.37e-05	0.0016	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—ACE—stomach cancer	4.34e-05	0.00159	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CA2—stomach cancer	4.33e-05	0.00158	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—UMPS—stomach cancer	4.33e-05	0.00158	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PGAM1—stomach cancer	4.22e-05	0.00154	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NT5E—stomach cancer	4.22e-05	0.00154	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—IL1B—stomach cancer	4.2e-05	0.00154	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	4.14e-05	0.00151	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	4.11e-05	0.0015	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CA—stomach cancer	4.09e-05	0.00149	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	4.07e-05	0.00149	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.03e-05	0.00147	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDH7A1—stomach cancer	4.03e-05	0.00147	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PLCE1—stomach cancer	4.03e-05	0.00147	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PDHA1—stomach cancer	4.02e-05	0.00147	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ECHS1—stomach cancer	4.02e-05	0.00147	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACAD8—stomach cancer	4.02e-05	0.00147	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	4e-05	0.00146	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—RPS6—stomach cancer	3.9e-05	0.00143	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—ACE—stomach cancer	3.87e-05	0.00142	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—UMPS—stomach cancer	3.86e-05	0.00141	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	3.82e-05	0.0014	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TYMP—stomach cancer	3.78e-05	0.00138	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—FADS1—stomach cancer	3.78e-05	0.00138	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	3.74e-05	0.00137	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	3.71e-05	0.00136	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CA—stomach cancer	3.65e-05	0.00133	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	3.63e-05	0.00133	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	3.63e-05	0.00133	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PDHA1—stomach cancer	3.59e-05	0.00131	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ECHS1—stomach cancer	3.59e-05	0.00131	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GMPR2—stomach cancer	3.59e-05	0.00131	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—VEGFA—stomach cancer	3.56e-05	0.0013	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SREBF2—stomach cancer	3.54e-05	0.00129	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—MAPK1—stomach cancer	3.5e-05	0.00128	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—RORA—stomach cancer	3.5e-05	0.00128	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	3.46e-05	0.00126	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	3.43e-05	0.00125	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—FADS1—stomach cancer	3.37e-05	0.00123	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TYMP—stomach cancer	3.37e-05	0.00123	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALDOB—stomach cancer	3.28e-05	0.0012	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—IDH3B—stomach cancer	3.28e-05	0.0012	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SUCLG1—stomach cancer	3.28e-05	0.0012	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SREBF2—stomach cancer	3.16e-05	0.00116	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.15e-05	0.00115	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—MAPK1—stomach cancer	3.12e-05	0.00114	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—RORA—stomach cancer	3.12e-05	0.00114	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	3.12e-05	0.00114	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.09e-05	0.00113	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.09e-05	0.00113	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TNF—stomach cancer	3.05e-05	0.00111	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALOX5—stomach cancer	3.05e-05	0.00111	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NDUFV1—stomach cancer	3.05e-05	0.00111	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NDUFS1—stomach cancer	3.05e-05	0.00111	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.05e-05	0.00111	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—DPYD—stomach cancer	3e-05	0.0011	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	2.94e-05	0.00107	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDOB—stomach cancer	2.93e-05	0.00107	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—HRAS—stomach cancer	2.81e-05	0.00103	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.76e-05	0.00101	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.75e-05	0.00101	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	2.73e-05	0.001	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALOX5—stomach cancer	2.72e-05	0.000994	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.72e-05	0.000994	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PGLS—stomach cancer	2.72e-05	0.000993	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BLVRB—stomach cancer	2.72e-05	0.000993	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—MAPK1—stomach cancer	2.68e-05	0.00098	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—DPYD—stomach cancer	2.68e-05	0.000978	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTT1—stomach cancer	2.65e-05	0.00097	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2A6—stomach cancer	2.62e-05	0.000958	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPAP2A—stomach cancer	2.59e-05	0.000948	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKR1C3—stomach cancer	2.55e-05	0.000932	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—HRAS—stomach cancer	2.51e-05	0.000916	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ENO1—stomach cancer	2.49e-05	0.000909	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.44e-05	0.000894	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.43e-05	0.000887	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—MAPK1—stomach cancer	2.39e-05	0.000875	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTT1—stomach cancer	2.37e-05	0.000865	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2A6—stomach cancer	2.34e-05	0.000855	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FBP1—stomach cancer	2.31e-05	0.000845	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NDUFA2—stomach cancer	2.31e-05	0.000845	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CKB—stomach cancer	2.31e-05	0.000845	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CA1—stomach cancer	2.31e-05	0.000845	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.28e-05	0.000833	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKR1C3—stomach cancer	2.27e-05	0.000832	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.23e-05	0.000815	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ENO1—stomach cancer	2.22e-05	0.000811	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CD44—stomach cancer	2.2e-05	0.000806	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.18e-05	0.000797	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLIN2—stomach cancer	2.17e-05	0.000794	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP2—stomach cancer	2.16e-05	0.000788	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—HRAS—stomach cancer	2.15e-05	0.000787	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.14e-05	0.000782	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CA2—stomach cancer	2.11e-05	0.000773	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2.11e-05	0.000772	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PGAM1—stomach cancer	2.06e-05	0.000753	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NT5E—stomach cancer	2.06e-05	0.000753	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	2.01e-05	0.000736	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	2.01e-05	0.000735	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CD44—stomach cancer	1.97e-05	0.000719	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLCE1—stomach cancer	1.96e-05	0.000718	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.96e-05	0.000718	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.95e-05	0.000712	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP2—stomach cancer	1.92e-05	0.000703	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—HRAS—stomach cancer	1.92e-05	0.000702	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.91e-05	0.000697	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.9e-05	0.000695	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UMPS—stomach cancer	1.88e-05	0.000689	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPP2R1A—stomach cancer	1.87e-05	0.000685	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTP1—stomach cancer	1.84e-05	0.000672	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HMOX1—stomach cancer	1.81e-05	0.000663	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CXCL8—stomach cancer	1.79e-05	0.000655	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.76e-05	0.000642	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PDHA1—stomach cancer	1.75e-05	0.00064	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ECHS1—stomach cancer	1.75e-05	0.00064	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TYMS—stomach cancer	1.71e-05	0.000625	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTM1—stomach cancer	1.69e-05	0.000618	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.68e-05	0.000616	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPP2R1A—stomach cancer	1.67e-05	0.000611	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.66e-05	0.000607	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TYMP—stomach cancer	1.65e-05	0.000602	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FADS1—stomach cancer	1.65e-05	0.000602	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTP1—stomach cancer	1.64e-05	0.0006	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HMOX1—stomach cancer	1.62e-05	0.000591	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.62e-05	0.000591	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CXCL8—stomach cancer	1.6e-05	0.000585	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ERCC2—stomach cancer	1.59e-05	0.000581	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.58e-05	0.000578	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.58e-05	0.000578	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SREBF2—stomach cancer	1.54e-05	0.000564	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TYMS—stomach cancer	1.52e-05	0.000557	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—RORA—stomach cancer	1.52e-05	0.000557	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM1—stomach cancer	1.51e-05	0.000551	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.5e-05	0.00055	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTHFR—stomach cancer	1.49e-05	0.000546	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.49e-05	0.000546	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDOB—stomach cancer	1.43e-05	0.000522	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ERCC2—stomach cancer	1.42e-05	0.000518	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CAV1—stomach cancer	1.38e-05	0.000503	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APOA1—stomach cancer	1.37e-05	0.000502	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.37e-05	0.000501	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTHFR—stomach cancer	1.33e-05	0.000487	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALOX5—stomach cancer	1.33e-05	0.000485	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.33e-05	0.000485	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.32e-05	0.000481	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—DPYD—stomach cancer	1.31e-05	0.000477	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.28e-05	0.000467	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CAV1—stomach cancer	1.23e-05	0.000449	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOA1—stomach cancer	1.23e-05	0.000448	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARG—stomach cancer	1.21e-05	0.000443	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.17e-05	0.000429	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTT1—stomach cancer	1.15e-05	0.000422	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2A6—stomach cancer	1.14e-05	0.000417	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKR1C3—stomach cancer	1.11e-05	0.000406	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALB—stomach cancer	1.09e-05	0.000398	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ENO1—stomach cancer	1.08e-05	0.000395	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARG—stomach cancer	1.08e-05	0.000395	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NOS3—stomach cancer	1.04e-05	0.000381	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.01e-05	0.00037	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALB—stomach cancer	9.71e-06	0.000355	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CD44—stomach cancer	9.59e-06	0.000351	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—stomach cancer	9.52e-06	0.000348	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NOS3—stomach cancer	9.29e-06	0.00034	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—stomach cancer	8.5e-06	0.000311	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPP2R1A—stomach cancer	8.16e-06	0.000298	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTP1—stomach cancer	8e-06	0.000293	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMOX1—stomach cancer	7.89e-06	0.000289	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TYMS—stomach cancer	7.44e-06	0.000272	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM1—stomach cancer	7.35e-06	0.000269	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ERCC2—stomach cancer	6.91e-06	0.000253	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTHFR—stomach cancer	6.5e-06	0.000238	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CAV1—stomach cancer	5.99e-06	0.000219	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOA1—stomach cancer	5.98e-06	0.000219	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—stomach cancer	5.86e-06	0.000214	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARG—stomach cancer	5.27e-06	0.000193	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—stomach cancer	5.23e-06	0.000191	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALB—stomach cancer	4.74e-06	0.000173	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NOS3—stomach cancer	4.53e-06	0.000166	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—stomach cancer	4.15e-06	0.000152	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—stomach cancer	2.55e-06	9.32e-05	CbGpPWpGaD
